mild® removes a major root cause of lumbar spinal stenosis (LSS) to improve back and leg pain.
mild® for Patients
An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
mild® for Healthcare Professionals
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
As new lumbar spinal stenosis (#LSS) procedures become available, practices are evolving the way they collaborate and work together to optimize patient care. The Mild Procedure’s patient selection process is quite simple, but requires imaging review, which is often not a part of Advanced Practice Providers’ (APPs) traditional education.
View our latest blog and listen to tips from leading APPs on how they quickly established comfort with imaging review in their practice, allowing them to “look for the ligament,” identify hypertrophic ligamentum flavum (HLF), and educate Mild patients independently.
Special thanks to Christine Christensen, Kelsey Kimball, Ashley Comer, and Jane Hartigan for their helpful insights.
Look for the ligament, even in patients with comorbidities!
If MRI imaging reveals hypertrophic ligamentum flavum ≥ 2.5mm in your lumbar spinal stenosis (#LSS) patient, they may be a candidate for the Mild Procedure. Mild is effective in treating patients with multiple stenosis types, including lateral and foraminal stenosis and has a safety profile equivalent to an ESI, but with lasting results.*
Make the #MOVE2mild early in your treatment algorithm to get your patients on the path to relief.
*Learn more and view clinical data at the #linkinbio.
Thankful for time together and helping others get back to doing what they love. In this season of gratitude, Vertos Medical is especially grateful to all the healthcare professionals who continuously put their patients first and help them find relief.
Case History: 77 year-old female with a previous lumbar hemilaminectomy at right L4-L5 and a 5-year history of epidural steroid injections (ESIs). The patient reported back pain of a 6 out of 10 that radiated to her right hip and leg. The patient was unable to stand or walk for more than 5 minutes but found relief from sitting or forward flexion.
Answer: Yes! The featured patient was an excellent Mild candidate who achieved significant improvement in quality of life and mobility. By her two-week follow-up, her standing time increased to 10 minutes and her pain was a 0 out of 10. By her 4-month follow-up visit, she continued to report no pain, had discontinued use of pain medications, and her standing/walking time had increased to 25 minutes.
Continuing our passion to offer safe, effective solutions to the lumbar spinal stenosis (#LSS) community, we are excited to announce new additions to Team Vertos!
Join us in welcoming District Sales Manager, Trevor Shoush, District Sales Specialist, Liam McCarthy, Customer Service Manager, Briana Figueroa, Customer Service Representative, Emily Haudenschild, Reimbursement Specialist, Lynell James, and NetSuite Administrator, Matt Nichols to Vertos Medical!
Interested in joining our team? Click the #linkinbio for employment opportunities.
In practices across the country, Advanced Practice Providers (APPs) are key players—trusted by patients and vital to the effective, efficient flow of a busy pain practice. When it comes to bringing lumbar spinal stenosis (#LSS) patients the benefits of the Mild Procedure, APPs are increasingly taking a leading role.
We recognize all that APPs do to help LSS patients find relief. We heard your needs, and that’s why we created the Vertos APP Advisory Board—a committee of dedicated professionals at all stages of their careers who are excited to help harness more resources, support and recognition for their colleagues.
Follow the #linkinbio to read the full blog and to meet our Vertos APP Advisory Board, or at https://bit.ly/2YVjJJO
Congrats to @drpryz, @anjumbux, Kailash Chandwani, @dr.khemlani, Shawn Puri, @painkiller_photos, and @harrysukumaran on publishing the 1st plain language summary in Pain Management. This new data helps Interventional Pain practices, referring specialties, and patients with lumbar spinal stenosis (#LSS) understand more about the Mild Procedure and its early place in the LSS treatment algorithm.
Read on to learn key takeaways and be sure to share the clinical article and plain language summary with your peers, so they know your practice offers minimally invasive treatment options at the #linkinbio!
New #MildProcedure data was revealed at the @nynj_painsymposium 2021 Annual Conference! This real-world, retrospective data confirms that lumbar spinal stenosis (#LSS) patients with hypertrophic ligamentum flavum and concomitant foraminal narrowing benefit from the Mild Procedure and should not be excluded from treatment.
Thank you to these outstanding physicians for their examination of treatment outcomes and showcasing how Mild patients, even with the presence of foraminal narrowing, experience significant improvement from debulking the ligament and relieving pressure on the nerves. Drs. @jassalmd, @anjumbux, Kailash Chandwani, @pain4eemd, @dr.khemlani, @nvadvancedpain, @drpryz, Shawn Puri, @paindoc13, @painkiller_photos, @dsayed123, @harrysukumaran.
To learn more on why Mild should be considered a first-line therapy for LSS patients, read the full blog at the #linkinbio.
Remove the problem and leave nothing behind with the Mild Procedure.
Up to 85% of spinal canal narrowing is caused by thickened ligament.* Mild removes a major root cause of lumbar spinal stenosis (#LSS) by debulking the hypertrophic ligamentum flavum, which restores space in the spinal canal and reduces compression of the nerves.
The Mild Procedure does not alter major structural anatomy. Additionally, no co-occurring or future treatment options are eliminated.
*Learn more and view clinical data at the #linkinbio or https://bit.ly/39GckQ6
How do you introduce patients with lumbar spinal stenosis (#LSS) to the minimally invasive Mild Procedure? Our short patient education video is THE all-in-one resource to explain how Mild candidacy is determined, what the procedure entails, and clinical outcomes.
Share it with your patients or embed it on your website to help them get moving with Mild at the #linkinbio.
Look for the ligament, it's a common problem, even in patients with comorbidities. Remove the problem with Mild and leave nothing behind.
Unlike more invasive procedures that can require a lengthy recovery, Mild patients typically resume normal activity within 24 hours with no restrictions.*
Mild patient, Ronnie, says “By the time I walked out [after the Mild Procedure], I went home, and I could get out. The first thing I wanted to do was start doing stuff. That was a big moment in my life emotionally.”
Help more lumbar spinal stenosis (#LSS) patients make the #MOVE2mild earlier in the treatment algorithm after the first ESI fails.
Hear Ronnie's story at the #linkinbio or https://bit.ly/3bm4TOQ
*Clinical data: https://bit.ly/39GckQ6
With growing data supporting the Mild Procedure as first-line therapy for patients with lumbar spinal stenosis (#LSS), more and more physicians and APPs are making the #MOVE2mild after the first epidural steroid injection (ESI) fails.
Hear from leading physician @drajayantonymd for his perspective on moving LSS patients to the Mild Procedure earlier in the treatment algorithm.
Challenge your own thinking around ESIs and learn how you can help your patients avoid epidural exhaustion at the #linkinbio.
We are honored to be ranked 7th in the @ocbizjournal 2021 list of Fastest-Growing Midsize Private Companies!
After witnessing the debilitating impact that lumbar spinal stenosis (#LSS) has on millions of patients’ quality-of-life annually, it became not just our goal, but our passion to expand the minimally invasive Mild Procedure treatment option to patients and practices nationwide.
Many thanks to our dedicated Mild providers and Team Vertos who’ve helped patients throw out those canes and walkers, find joy again, and get back to what matters most to them - in a minimally invasive way.
View article at the #linkinbio or here: https://bit.ly/3BSUENZ
Mild Procedure training in action! Team Vertos and Mild physicians have been showcasing the minimally invasive procedure for lumbar spinal stenosis (#LSS) at recent in-person society hosted labs throughout the U.S.
Interested in adding Mild to your practice? Train virtually 11/17 or 12/8 and learn about patient selection, imaging, clinical data, Mild instrumentation, and procedure steps.
Inquire about training at the #linkinbio or https://bit.ly/3m6JQ80
#MOVE2mild to evolve your practice’s standard of care and get your patients on the path to lasting relief.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.